Summary

A man who returned to Switzerland from a South American trip in late April was admitted to University Hospital Zurich with a hantavirus infection. The reference laboratory at University Hospital Geneva confirmed Andes virus, a hantavirus variant prevalent in South America. The patient is being treated under isolation conditions. His wife, also a returning traveler, has shown no symptoms to date and is in self-isolation.

People

  • Affected patient (returning traveler from South America; isolated at USZ)

Topics

  • Infectious diseases
  • Public health
  • Epidemiological surveillance
  • South American travel

Clarus Lead

The Federal Office of Public Health (BAG) rates the risk to the Swiss population as low. In contrast to European hantaviruses, which are primarily transmitted through rodent excretions, human-to-human transmission of the American Andes virus occurs only with close contact – a scenario that the BAG considers unlikely. However, cantonal authorities are nonetheless checking preventively whether the patient had contact with other individuals during his illness phase.

Detailed Summary

The infected patient sought treatment at University Hospital Zurich after perceiving disease symptoms on the advice of his general practitioner, where he was immediately isolated. The diagnosis was confirmed by a test at the reference laboratory of University Hospital Geneva. The identified Andes virus is a South American hantavirus variant that differs epidemiologically from European variants: while the latter are primarily transmitted through contact with infected rodents, direct human-to-human transmission has been rarely documented for Andes virus – but exclusively in cases of close personal exposure.

As a reference hospital, USZ has the necessary capacity and safety precautions to treat such cases. The BAG coordinates the response in close coordination with the Canton of Zurich, both university hospitals, and the WHO. Historically, hantavirus fever remains rare in Switzerland: in recent years, 0 to 6 cases per year have been reported, with the vast majority resulting from infections acquired abroad.

Key Messages

  • A South American returning traveler was admitted to USZ with Andes virus infection and isolated
  • Andes virus rarely permits human-to-human transmission, only with close contact
  • The BAG assesses the population risk as low and is actively monitoring the situation
  • Hantavirus infections are historically rare in Switzerland and mostly imported

Critical Questions

  1. Source Validity: On what epidemiological evidence is the BAG's assessment that human-to-human transmission of Andes virus is "rare" based – are there quantified data on documented cases?

  2. Contact Tracing: What specific criteria do cantonal authorities use to define "close contact" in the follow-up phase, and how is the wife being monitored despite being asymptomatic?

  3. Transmission Risk: Could travel on a cruise ship (mentioned as context for several hantavirus cases) present an elevated exposure risk for other passengers beyond the isolation conditions?

  4. Diagnostic Capacity: Do all Swiss hospitals have testing capacity for Andes virus, or is the Geneva reference laboratory the only verification facility – and how long does the testing process take?

  5. Prevention for Travelers: Are there specific travel advisories or preventive measures for Swiss citizens traveling to South America to minimize hantavirus exposure?

  6. Treatment Options: What therapeutic options are available for Andes virus infections, and do they differ from treatment protocols for European hantaviruses?


Sources

Primary Source: Federal Office of Public Health (BAG) – Press Release: Hantavirus Case in Switzerland – https://www.news.admin.ch/de/newnsb/p--A7yPSfxdBqR0N9kZMC

Supplementary Resources:

  • BAG Information Portal Communicable Diseases: www.idd.bag.admin.ch/de/diseases/overview
  • BAG Information on Hantavirus: www.bag.admin.ch/de/hantavirus-infektionen

Verification Status: ✓ 06.05.2026


This text was created with the support of an AI model. Editorial Responsibility: clarus.news | Fact-Check: 06.05.2026